Okinawa Prefecture Promotes Clinic Trial Business
This article was originally published in PharmAsia News
To promote clinic trials business and encourage pharmaceutical research and development in Okinawa Prefecture, the local government will set up a network to connect patients, hospitals and pharmaceutical companies. The core members include the Japan Medical Association Okinawa branch and Ryukyu University Hospital. Okinawa government will match pharmaceutical companies conducting clinic trials with local patients and support drug makers setting up facilities and investing in research. After a series of preparations, actual clinic trails are estimated to start beginning in 2009. (Click here for more - Japanese language
You may also be interested in...
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.